Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44

Abstract

our study has discovered a novel TIC surface marker, CD44, which can be utilized to enrich efficiently the TICs in ESCC. These findings will be useful for further studies of these cells and exploring therapeutic approaches.